Skip to main content
Clinical Trials/NCT06357559
NCT06357559
Not yet recruiting
Not Applicable

Optical Coherence Tomography Angiography Changes in Choroidal Neovascularization in High Myopia

Sohag University0 sites100 target enrollmentApril 30, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myopic Choroidal Neovascularisation
Sponsor
Sohag University
Enrollment
100
Primary Endpoint
Describing the Choroidal Neovascularization in High Myopic Patients diagnosed by OCTA
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

To Analyze the Ability of Optical Coherence Tomography Angiography ( OCT-A ) to detect the presence of myopic Choroidal Neovascularization and to describe the structural features of Myopic CNV..

Detailed Description

To Analyze the Ability of Optical Coherence Tomography Angiography ( OCT-A ) to detect the presence of myopic Choroidal Neovascularization and to describe the structural features of Myopic CNV.. regarding the size , shape , core , margin , Appearance , and activity of CNV..

Registry
clinicaltrials.gov
Start Date
April 30, 2024
End Date
December 1, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Hamdy Abdelrahman

Dr.

Sohag University

Eligibility Criteria

Inclusion Criteria

  • All Patients with High Myopia ( \> -6 D or Axial Length \> 26.5 mm ) with Fundoscopic Changes Consistent with CNVM , with Clear Media are Subjected to OCTA

Exclusion Criteria

  • Patients with Treated CNVs , or with other Causes of CNVs including :
  • Neovascular AMD , Idiopathic CNV , Traumatic , Inflammatory , Neoplastic , Degenerative ..

Outcomes

Primary Outcomes

Describing the Choroidal Neovascularization in High Myopic Patients diagnosed by OCTA

Time Frame: 1 year

Describing the Choroidal Neovascularization in High Myopic Patients diagnosed by OCTA Regarding its Activity ..

Similar Trials